This course should provide you with a deeper knowledge of drug pharmacokinetics and pharmacodynamics, as well as with a deeper understanding of how pharmaceutical and biotechnology companies discover new drugs, and how larger companies manage their drug discovery portfolios. You will expand your knowledge of the processes by which potential drugs are identified, optimized, and characterized in the preclinical setting, and begin to understand the process by which companies evaluate what they have and make decisions to move forward or to terminate a project.
This course will provide you with valuable information if you are intending to work for a pharmaceutical company, company that provides products or services to pharmaceutical companies, or a management consulting firm. The types of positions that you might consider based on information in this course include: consulting, business development, and project management.
You are expected to already know the fundamental terminology and timelines of drug discovery, from initial idea to IND. ALS330 is a requirement for this course. We will explore additional case studies from industry that exemplify state-of-the-art drug discovery technologies and managerial practices. This is a science/technical course that will freely intersperse business and regulatory issues into the lectures and assignments.
ALS 330, or permission of instructor (PPC, PPM)
After completing this course, you should have:
(1) Advanced knowledge about Pharmacokinetics and Pharmacodynamics;
(2) Additional examples that expand your knowledge of the overall process of the discovery of small molecules for human health;
(3) Additional appreciation of the scientific challenges and difficulties facing drug discovery scientists and managers at different stages in the drug discovery process;
(4) Ability to contribute to the assessment of technical documents describing a drug discovery project, which might be part of a company portfolio or a potential in-licensing or out-licensing opportunity.
(5) Ability to contribute to the management of a drug discovery project.